Associated Papers
Novel therapeutic opportunities for familial lecithin:cholesterol acyltransferase deficiency: promises and challenges.
Vitali C et al.
Current Opinion in Lipidology, 2023
A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency.
Vitali C et al.
Journal of Lipid Research, 2022
35065092 (PubMed )
Supplement: mmc1.pdf
LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred.
Mehta R et al.
Lipids in Health and Disease, 2021
Current Status of Familial LCAT Deficiency in Japan.
Kuroda M et al.
Journal of Atherosclerosis and Thrombosis, 2021
Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020.
Pavanello C et al.
Current Opinion in Lipidology, 2020
The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.
Fountoulakis N et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 2019
The Effect of Natural LCAT Mutations on the Biogenesis of HDL.
Fotakis P et al.
Biochemistry, 2015
Select a paper to view details